Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (26)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by RYAN, P.
Right arrow Articles by McMICHAEL, A. J
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by RYAN, P.
Right arrow Articles by McMICHAEL, A. J
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1993 Oxford University Press

research-article

Tumours of the Brain and Presence of Antibodies to Toxoplasma gondii

PHILIP RYAN*, SUSAN F HURLEY**, ALAN M JOHNSON{dagger}, MICHAEL SALZBERG**, MARJORIE W LEE*, J BRIAN NORTH{ddagger}, JOHN J McNEIL** and ANTHONY J McMICHAEL*

* Department of Community Medicine, University of Adelaid GPO Box 498, Adelaide 5001, South Australia, Australia
** Department of Social and Preventive Medicine, Monash Medical School Alfred Hospital, Commercial Road, Prahran 3181, Victoria, Australia
{dagger} Department of Microbiology, School of Biological and Biomedical Sciences, University of Technology Sydney Westbourne St, Gore Hill 2065, New South Wales, Australia
{ddagger} Department of Neurosurgery, Royal Adelaide Hospital North Terrace, Adelaide 5000, South Australia, Australia

The possible association between prior infection with the protozoan Toxoplasma gondii and development of brain tumours was investigated as part of two Australian population-based case-control studies of adult brain tumours. One study, based in Adelaide, South Australia, collected blood from 73 subjects with glioma, 53 subjects with meningioma and 348 controls. The other study, based in Melbourne, Victoria, collected blood from 44 subjects with glioma and 67 controls. All tumours had been verified histologically. IgG antibodies to T. gondii ware measured using Enzyme Unked Immunosorbent Assay (ELISA) techniques. In both the centre-specific and combined analyses, there was no difference between subjects with glioma and controls in the prevalence of antibody test-positivity (35% test-positive in glioma versus 33% in controls, age-, sex- and centre-adjusted odds ratio (OR)=1.00, 95% confidence interval (Cl): 0.64–1.56). In the Adelaide study, there was a statistically significant increased risk of meningioma associated with antibody test-positivity (47% test-positive in meningloma versus 31% in controls, P=0.02, adjusted OR=2.09, 95% Cl: 1.14–3.83). Our results do not support the hypothesis that antibody positivity to T. gondii is a risk factor for glioma, but suggest that it might be associated with meningioma.

Received 1 October 1992


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Proc R Soc BHome page
J.P Webster, P.H.L Lamberton, C.A Donnelly, and E.F Torrey
Parasites as causative agents of human affective disorders? The impact of anti-psychotic, mood-stabilizer and anti-parasite medication on Toxoplasma gondii's ability to alter host behaviour
Proc R Soc B, April 22, 2006; 273(1589): 1023 - 1030.
[Abstract] [Full Text] [PDF]


Home page
Neuro Oncol DukeHome page
M. Wrensch, Y. Minn, T. Chew, M. Bondy, and M. S. Berger
Epidemiology of primary brain tumors: Current concepts and review of the literature
Neuro-oncol, October 1, 2002; 4(4): 278 - 299.
[Abstract] [PDF]


Home page
Arch NeurolHome page
O. H. Del Brutto, P. R. Castillo, I. X. Mena, and A. X. Freire
Neurocysticercosis Among Patients With Cerebral Gliomas
Arch Neurol, September 1, 1997; 54(9): 1125 - 1128.
[Abstract] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.